Autoregulated paracellular clearance of amyloid-β across the blood-brain barrier

Science Advances

Volumn 1, Issue 8, 2015, Pages

  Keaney, James ^a   Walsh, Dominic M ^b   O’Malley, Tiernan ^b   Hudson, Natalie ^a   Crosbie, Darragh E ^a   Loftus, Teresa ^c   Sheehan, Florike ^c   McDaid, Jacqueline ^a   Humphries, Marian M ^a   Callanan, John J ^d,e   Brett, Francesca M ^c   Farrell, Michael A ^c   Humphries, Peter ^a   Campbell, Matthew ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BEAUMONT HOSPITAL   (Ireland)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

^e ROSS UNIVERSITY SCHOOL OF VETERINARY MEDICINE   (Saint Kitts and Nevis)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEINS; LIVING SYSTEMS STUDIES; MEDICAL PROBLEMS; PROTEINS; TISSUE HOMEOSTASIS;

AMYLOID BETAS; BLOOD-BRAIN BARRIER; COGNITIVE FUNCTIONS; DOWN-REGULATION; ENDOTHELIAL RECEPTOR; THERAPEUTIC TARGETS; TIGHT JUNCTIONS; VASCULAR ENDOTHELIUM;

BLOOD;

EID: 84976284861     PISSN: None     EISSN: 23752548     Source Type: Journal    
DOI: 10.1126/sciadv.1500472     Document Type: Article

References (31)

1. M. Prince, R. Bryce, E. Albanese, A. Wimo, W. Ribeiro, C. P. Ferri, The global prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dement. 9, 63–75.e2 (2013).
2. D.W.Dicksen,Thepathogenesisofsenileplaques.J.Neuropathol.Exp.Neurol.56,321–339(1997).
3. A. E. Roher, K. C. Palmer, V. Chau, M. J. Ball, Isolation and chemical characterization of Alzheimer’s disease paired helical filament cytoskeletons: Differentiation from amyloid plaque core protein. J. Cell Biol. 107, 2703–2716 (1988).
4. G. M. Shankar, S. Li, T. H. Mehta, A. Garcia-Munoz, N. E. Shepardson, I. Smith, F. M. Brett, M. A. Farrell, M. J. Rowan, C. A. Lemere, C. M. Regan, D. M. Walsh, B. L. Sabatini, D. J. Selkoe, Amyloid-b protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nat. Med. 14, 837–842 (2008).
5. K. G. Mawuenyega, W. Sigurdson, V. Ovod, L. Munsell, T. Kasten, J. C. Morris, K. E. Yarasheski, R. J. Bateman, Decreased clearance of CNS b-amyloid in Alzheimer’s disease. Science 330, 1774 (2010).
6. A. P. Sagare, R. D. Bell, B. V. Zlokovic, Neurovascular defects and faulty amyloid-b vascular clearance in Alzheimer’s disease. J. Alzheimers Dis. 33 (Suppl. 1), S87–S100 (2013).
7. E. Auriel, S. M. Greenberg, The pathophysiology and clinical presentation of cerebral amyloid angiopathy. Curr. Atheroscler. Rep. 14, 343–350 (2012).
8. N. J. Abbott, A. A. K. Patabendige, D. E. M. Dolman, S. R. Yusof, D. J. Begley, Structure and function of the blood-brain barrier. Neurobiol. Dis. 37, 13–25 (2010).
9. B. Obermeier, R. Daneman, R. M. Ransohoff, Development, maintenance and disruption of the blood-brain barrier. Nat. Med. 19, 1584–1596 (2013).
10. R. Daneman, L. Zhou, D. Agalliu, J. D. Cahoy, A. Kaushal, B. A. Barres, The mouse blood-brain barrier transcriptome: A new resource for understanding the development and function of brain endothelial cells. PLOS One 5, e13741 (2010).
11. N. R. Saunders, R. Daneman, K. M. Dziegielewska, S. A. Liddelow, Transporters of the blood–brain and blood–CSF interfaces in development and in the adult. Mol. Aspects Med. 34, 742–752 (2013).
12. R. Deane, S. D. Yan, R. K. Submamaryan, B. LaRue, S. Jovanovic, E. Hogg, D. Welch, L. Manness, C. Lin, J. Yu, H. Zhu, J. Ghiso, B. Frangione, A. Stern, A. M. Schmidt, D. L. Armstrong, B. Arnold, B. Liliensiek, P. Nawroth, F. Hofman, M. Kindy, D. Stern, B. Zlokovic, RAGE mediates amyloid-b peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med. 9, 907–913 (2003).
13. R. Deane, Z. Wu, A. Sagare, J. Davis, S. D. Yan, K. Hamm, F. Xu, M. Parisi, B. LaRue, H. W. Hu, P. Spijkers, H. Guo, X. Song, P. J. Lenting, W. E. Van Nostrand, B. V. Zlokovic, LRP/amyloid b-peptide interaction mediates differential brain efflux of Ab isoforms. Neuron 43, 333–344 (2004).
14. A. Carrano, J. J. M. Hoozemans, S. M. van der Vies, A. J. M. Rozemuller, J. van Horssen, H. E. de Vries, Amyloid beta induces oxidative stress-mediated blood–brain barrier changes in capillary amyloid angiopathy. Antioxid. Redox Signal. 15, 1167–1178 (2011).
15. K. E. Biron, D. L. Dickstein, R. Gopaul, W. A. Jeffries, Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer’s disease. PLOS One 6, e23789 (2011).
16. A. M. Hartz, B. Bauer, E. L. Soldner, A. Wolf, S. Boy, R. Backhaus, I. Mihaljevic, U. Bogdahn, H. H. Klünemann, G. Schuierer, F. Schlachetzki, Amyloid-b contributes to blood–brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Stroke 43, 514–523 (2012).
17. D. M. Walsh, A. Lomakin, G. B. Benedek, M. M. Condron, D. B. Teplow, Amyloid b-protein fibrillogenesis: Detection of a protofibrillar intermediate. J. Biol. Chem. 272, 22364–22372 (1997).
18. T. T. O’Malley, N. A. Oktaviani, D. Zhang, A. Lomakin, B. O’Nuallain, S. Linse, G. B. Benedek, M. J. Rowan, F. A. A. Mulder, D. M. Walsh, Ab dimers differ from monomers in structural propensity, aggregation paths, and population of synaptotoxic assemblies. Biochem. J. 461, 413–426 (2014).
19. M. Campbell, A.-S. Kiang, P. F. Kenna, C. Kerskens, C. Blau, L. O’Dwyer, A. Tivnan, J. A. Kelly, B. Brankin, G.-J. Farrar, P. Humphries, RNAi-mediated reversible opening of the blood-brain barrier. J. Gene Med. 10, 930–947 (2008).
20. T. Kawarabayashi, L. H. Younkin, T. C. Saido, M. Shoji, K. H. Ashe, S. G. Younkin, Age-dependent changes in brain, CSF, and plasma amyloid b protein in the Tg2576 transgenic mouse model of Alzheimer’s disease. J. Neurosci. 21, 372–381 (2001).
21. R. M. J. Deacon, J. N. P. Rawlins, T-maze alternation in the rodent. Nat. Protoc. 1, 7–12 (2006).
22. D. Goldblum, A. Kipfer-Kauer, G.-M. Sarra, S. Wolf, B. E. Frueh, Distribution of amyloid precursor protein and amyloid-b immunoreactivity in DBA/2J glaucomatous mouse retinas. Invest. Ophthalmol. Vis. Sci. 48, 5085–5090 (2007).
23. T. Kanekiyo, H. Xu, G. Bu, ApoE and Ab in Alzheimer’s disease: Accidental encounters or partners? Neuron 81, 740–754 (2014).
24. A. Goate, M.-C. Chartier-Harlin, M. Mullan, J. Brown, F. Crawford, L. Fidani, L. Giuffra, A. Haynes, N. Irving, L. James, R. Mant, P. Newton, K. Rooke, P. Roques, C. Talbot, M. Pericak-Vance, A. Roses, R. Williamson, M. Rossor, M. Owen, J. Hardy, Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349, 706–707 (1991).
25. S. Gandy, Lifelong management of amyloid-beta metabolism to prevent Alzheimer’s disease. N. Engl. J. Med. 367, 864–865 (2012).
26. T. Nitta, M. Hata, S. Gotoh, Y. Seo, H. Sasaki, N. Hashimoto, M. Furuse, S. Tsukita, Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice. J. Cell Biol. 161, 653–660 (2003).
27. M. Campbell, F. Hanrahan, O. L. Gobbo, M. E. Kelly, A.-S. Kiang, M. M. Humphries, A. T. H. Nguyen, E. Ozaki, J. Keaney, C. W. Blau, C. M. Kerskens, S. D. Cahalan, J. J. Callanan, E. Wallace, G. A. Grant, C. P. Doherty, P. Humphries, Targeted suppression of claudin-5 decreases cerebral oedema and improves cognitive outcome following traumatic brain injury. Nat. Commun. 3, 849 (2012).
28. L. M. Tai, K. A. Holloway, D. K. Male, A. J. Loughlin, I. A. Romero, Amyloid-b-induced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation. J. Cell. Mol. Med. 14, 1101–1112 (2010).
29. E. Karran, M. Mercken, B. De Strooper, The amyloid cascade hypothesis for Alzheimer’s disease: An appraisal for the development of therapeutics. Nat. Rev. Drug Discov. 10, 698–712 (2011).
30. J. H. Toyn, M. K. Ahlijanian, Interpreting Alzheimer’s disease clinical trials in light of the effects on amyloid-b. Alzheimers Res. Ther. 6, 14 (2014).
31. J. M. McDonald, N. J. Cairns, L. Taylor-Reinwald, D. Holtzman, D. M. Walsh, The levels of water-soluble and triton-soluble Ab are increased in Alzheimer’s disease brain. Brain Res. 1450, 138–147 (2012).